Key result
Transcarotid transcatheter aortic valve implantation using balloon-expandable and self-expandable valves achieved 100% device success with similar safety and efficacy at 30 days.
Why the study?
Transcarotid TAVI is an alternative when transfemoral access is impossible, but short-term results comparing balloon-expandable and self-expandable valves have not been fully determined.
Does transcarotid TAVI using balloon-expandable valves compared to self-expandable valves improve short-term safety and efficacy in patients with severe symptomatic aortic stenosis?
Cohort (n=39)
No
Does transcarotid TAVI using balloon-expandable valves compared to self-expandable valves improve short-term safety and efficacy in patients with severe symptomatic aortic stenosis?
Transcarotid TAVI using either balloon-expandable or self-expandable valves demonstrates comparable and high short-term safety and efficacy for patients ineligible for transfemoral access.
Answers are grounded in this paper and cite their sources.
Supports transcarotid TAVI feasibility when transfemoral access is infeasible; leaves open randomized comparisons of valve types.
INTRODUCTION: Transfemoral access (TF) is the preferred access for transcatheter aortic valve implantation (TAVI). Transcarotid TAVI (TC-TAVI) is an alternative for patients in whom TF-TAVI is impossible. Two types of valves - balloon-expandable (BE) and self-expandable (SE) - can be used in TC-TAVI procedures. AIM: Comparison of the short-term results of patients treated with TC-TAVI using BE and SE valves. MATERIAL AND METHODS: = 29). Preoperative characteristics, operative and postoperative results, and 30-days mortality were compared. We did not observe statistically significant differences between BE-TAVI and SE-TAVI in periprocedural and 30-day mortality, or the number of strokes/TIA. Also TTE parameters and NYHA class showed similar improvement at 30 days in both groups. CONCLUSIONS: TC-TAVI using balloon-expandable and self-expandable valves showed similar safety and efficacy in 30 days follow-up.
No takes yet. Share an insight, caveat, or question.
Hudziak et al. (2021) conducted a cohort in Severe symptomatic aortic stenosis (n=39). Balloon-expandable valves vs. Self-expandable valves was evaluated on Device success. Transcarotid transcatheter aortic valve implantation using balloon-expandable and self-expandable valves achieved 100% device success with similar safety and efficacy at 30 days.
Synapse has enriched 10 related papers. Consider them for comparative context: